For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

Table 1 summarises the evidence gaps and ongoing studies that might address them. Information about evidence status is derived from the external assessment group's report. More information on the ...

NICE's assessment of digital technologies to support self-management of chronic obstructive pulmonary disease (COPD) recommends that Active+me ... in the NHS while more evidence is generated. This ...

Speaker Mike Johnson (R-La.) is looking at a plan B to fund the government ahead of Friday’s shutdown deadline as Republicans inside and outside the Capitol, including President-elect Trump and ...